ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dry Eye Syndrome Drugs Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-38M5918
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Dry Eye Syndrome Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Dry Eye Syndrome Drugs Market Research Report 2025

Code: QYRE-Auto-38M5918
Report
May 2025
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
AbbVie
Alcon
Santen Pharma
Johnson & Johnson
Bausch & Lomb
Thea Pharmaceuticals
Ursapharm
SIMILASAN
Akorn
United Laboratories
Sun Pharmaceutical
Jianfeng Group
OmniVision Pharma
ROHTO
Prestige Consumer Healthcare
Lion
Kenvue (VISINE)

Dry Eye Syndrome Drugs Market Size

The global market for Dry Eye Syndrome Drugs was valued at US$ 5876 million in the year 2024 and is projected to reach a revised size of US$ 7959 million by 2031, growing at a CAGR of 4.5% during the forecast period.

Dry Eye Syndrome Drugs Market

Dry Eye Syndrome Drugs Market

Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment. In this report, we mainly study the drugs and eye drops for dry eye.
The Dry Eye Syndrome market is driven by the rising prevalence of dry eye conditions globally, fueled by aging populations, increased screen time, and lifestyle-related factors. The widespread use of digital devices has significantly contributed to eye strain and reduced blink rates, leading to a surge in dry eye cases, especially among younger demographics. Additionally, growing awareness of ocular health and improved diagnosis through advanced diagnostic tools have increased patient identification and treatment rates. The introduction of innovative therapies, including anti-inflammatory eye drops, tear-stimulating drugs, and device-based treatments, is also expanding the market landscape.
Despite growing demand, the Dry Eye Syndrome market faces several challenges, including underdiagnosis, variable symptoms, and limited long-term treatment efficacy. Many patients remain undiagnosed due to the overlap of symptoms with other ocular conditions and the subjective nature of the disease. Current treatments often offer only temporary relief rather than a cure, leading to poor adherence and patient dissatisfaction. Moreover, the development of new therapies is hindered by the complex pathophysiology of the condition, which involves both aqueous and evaporative components. Addressing these challenges requires improved diagnostic criteria, personalized treatment approaches, and increased investment in research and clinical trials.
This report aims to provide a comprehensive presentation of the global market for Dry Eye Syndrome Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dry Eye Syndrome Drugs.
The Dry Eye Syndrome Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dry Eye Syndrome Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dry Eye Syndrome Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Dry Eye Syndrome Drugs Market Report

Report Metric Details
Report Name Dry Eye Syndrome Drugs Market
Accounted market size in year US$ 5876 million
Forecasted market size in 2031 US$ 7959 million
CAGR 4.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Homecare
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AbbVie, Alcon, Novartis, Santen Pharma, Johnson & Johnson, Bausch & Lomb, Thea pharmaceuticals, URSAPHARM, SIMILASAN, Akorn, United Laboratories, Sun Pharmaceutical, Jianfeng Group, OmniVision Pharma, Rohto, Prestige Consumer Healthcare, LION, Kenvue (VISINE)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Dry Eye Syndrome Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Dry Eye Syndrome Drugs Market growing?

Ans: The Dry Eye Syndrome Drugs Market witnessing a CAGR of 4.5% during the forecast period 2025-2031.

What is the Dry Eye Syndrome Drugs Market size in 2031?

Ans: The Dry Eye Syndrome Drugs Market size in 2031 will be US$ 7959 million.

Who are the main players in the Dry Eye Syndrome Drugs Market report?

Ans: The main players in the Dry Eye Syndrome Drugs Market are AbbVie, Alcon, Novartis, Santen Pharma, Johnson & Johnson, Bausch & Lomb, Thea pharmaceuticals, URSAPHARM, SIMILASAN, Akorn, United Laboratories, Sun Pharmaceutical, Jianfeng Group, OmniVision Pharma, Rohto, Prestige Consumer Healthcare, LION, Kenvue (VISINE)

What are the Application segmentation covered in the Dry Eye Syndrome Drugs Market report?

Ans: The Applications covered in the Dry Eye Syndrome Drugs Market report are Hospitals, Clinics, Homecare, Others

What are the Type segmentation covered in the Dry Eye Syndrome Drugs Market report?

Ans: The Types covered in the Dry Eye Syndrome Drugs Market report are Artificial Tears, Anti-inflammatory Drugs, Other

Recommended Reports

Dry Eye Treatments

Ocular Disease Drugs

Eye Care Devices

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dry Eye Syndrome Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Artificial Tears
1.2.3 Anti-inflammatory Drugs
1.2.4 Other
1.3 Market by Application
1.3.1 Global Dry Eye Syndrome Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Homecare
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dry Eye Syndrome Drugs Market Perspective (2020-2031)
2.2 Global Dry Eye Syndrome Drugs Growth Trends by Region
2.2.1 Global Dry Eye Syndrome Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Dry Eye Syndrome Drugs Historic Market Size by Region (2020-2025)
2.2.3 Dry Eye Syndrome Drugs Forecasted Market Size by Region (2026-2031)
2.3 Dry Eye Syndrome Drugs Market Dynamics
2.3.1 Dry Eye Syndrome Drugs Industry Trends
2.3.2 Dry Eye Syndrome Drugs Market Drivers
2.3.3 Dry Eye Syndrome Drugs Market Challenges
2.3.4 Dry Eye Syndrome Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dry Eye Syndrome Drugs Players by Revenue
3.1.1 Global Top Dry Eye Syndrome Drugs Players by Revenue (2020-2025)
3.1.2 Global Dry Eye Syndrome Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Top Dry Eye Syndrome Drugs Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Dry Eye Syndrome Drugs Revenue
3.4 Global Dry Eye Syndrome Drugs Market Concentration Ratio
3.4.1 Global Dry Eye Syndrome Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dry Eye Syndrome Drugs Revenue in 2024
3.5 Global Key Players of Dry Eye Syndrome Drugs Head office and Area Served
3.6 Global Key Players of Dry Eye Syndrome Drugs, Product and Application
3.7 Global Key Players of Dry Eye Syndrome Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Dry Eye Syndrome Drugs Breakdown Data by Type
4.1 Global Dry Eye Syndrome Drugs Historic Market Size by Type (2020-2025)
4.2 Global Dry Eye Syndrome Drugs Forecasted Market Size by Type (2026-2031)
5 Dry Eye Syndrome Drugs Breakdown Data by Application
5.1 Global Dry Eye Syndrome Drugs Historic Market Size by Application (2020-2025)
5.2 Global Dry Eye Syndrome Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Dry Eye Syndrome Drugs Market Size (2020-2031)
6.2 North America Dry Eye Syndrome Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Dry Eye Syndrome Drugs Market Size by Country (2020-2025)
6.4 North America Dry Eye Syndrome Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dry Eye Syndrome Drugs Market Size (2020-2031)
7.2 Europe Dry Eye Syndrome Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Dry Eye Syndrome Drugs Market Size by Country (2020-2025)
7.4 Europe Dry Eye Syndrome Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Dry Eye Syndrome Drugs Market Size (2020-2031)
8.2 Asia-Pacific Dry Eye Syndrome Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Dry Eye Syndrome Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Dry Eye Syndrome Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Dry Eye Syndrome Drugs Market Size (2020-2031)
9.2 Latin America Dry Eye Syndrome Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Dry Eye Syndrome Drugs Market Size by Country (2020-2025)
9.4 Latin America Dry Eye Syndrome Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dry Eye Syndrome Drugs Market Size (2020-2031)
10.2 Middle East & Africa Dry Eye Syndrome Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Dry Eye Syndrome Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Dry Eye Syndrome Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Dry Eye Syndrome Drugs Introduction
11.1.4 AbbVie Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.1.5 AbbVie Recent Development
11.2 Alcon
11.2.1 Alcon Company Details
11.2.2 Alcon Business Overview
11.2.3 Alcon Dry Eye Syndrome Drugs Introduction
11.2.4 Alcon Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.2.5 Alcon Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Dry Eye Syndrome Drugs Introduction
11.3.4 Novartis Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Santen Pharma
11.4.1 Santen Pharma Company Details
11.4.2 Santen Pharma Business Overview
11.4.3 Santen Pharma Dry Eye Syndrome Drugs Introduction
11.4.4 Santen Pharma Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.4.5 Santen Pharma Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Dry Eye Syndrome Drugs Introduction
11.5.4 Johnson & Johnson Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.5.5 Johnson & Johnson Recent Development
11.6 Bausch & Lomb
11.6.1 Bausch & Lomb Company Details
11.6.2 Bausch & Lomb Business Overview
11.6.3 Bausch & Lomb Dry Eye Syndrome Drugs Introduction
11.6.4 Bausch & Lomb Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.6.5 Bausch & Lomb Recent Development
11.7 Thea pharmaceuticals
11.7.1 Thea pharmaceuticals Company Details
11.7.2 Thea pharmaceuticals Business Overview
11.7.3 Thea pharmaceuticals Dry Eye Syndrome Drugs Introduction
11.7.4 Thea pharmaceuticals Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.7.5 Thea pharmaceuticals Recent Development
11.8 URSAPHARM
11.8.1 URSAPHARM Company Details
11.8.2 URSAPHARM Business Overview
11.8.3 URSAPHARM Dry Eye Syndrome Drugs Introduction
11.8.4 URSAPHARM Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.8.5 URSAPHARM Recent Development
11.9 SIMILASAN
11.9.1 SIMILASAN Company Details
11.9.2 SIMILASAN Business Overview
11.9.3 SIMILASAN Dry Eye Syndrome Drugs Introduction
11.9.4 SIMILASAN Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.9.5 SIMILASAN Recent Development
11.10 Akorn
11.10.1 Akorn Company Details
11.10.2 Akorn Business Overview
11.10.3 Akorn Dry Eye Syndrome Drugs Introduction
11.10.4 Akorn Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.10.5 Akorn Recent Development
11.11 United Laboratories
11.11.1 United Laboratories Company Details
11.11.2 United Laboratories Business Overview
11.11.3 United Laboratories Dry Eye Syndrome Drugs Introduction
11.11.4 United Laboratories Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.11.5 United Laboratories Recent Development
11.12 Sun Pharmaceutical
11.12.1 Sun Pharmaceutical Company Details
11.12.2 Sun Pharmaceutical Business Overview
11.12.3 Sun Pharmaceutical Dry Eye Syndrome Drugs Introduction
11.12.4 Sun Pharmaceutical Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.12.5 Sun Pharmaceutical Recent Development
11.13 Jianfeng Group
11.13.1 Jianfeng Group Company Details
11.13.2 Jianfeng Group Business Overview
11.13.3 Jianfeng Group Dry Eye Syndrome Drugs Introduction
11.13.4 Jianfeng Group Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.13.5 Jianfeng Group Recent Development
11.14 OmniVision Pharma
11.14.1 OmniVision Pharma Company Details
11.14.2 OmniVision Pharma Business Overview
11.14.3 OmniVision Pharma Dry Eye Syndrome Drugs Introduction
11.14.4 OmniVision Pharma Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.14.5 OmniVision Pharma Recent Development
11.15 Rohto
11.15.1 Rohto Company Details
11.15.2 Rohto Business Overview
11.15.3 Rohto Dry Eye Syndrome Drugs Introduction
11.15.4 Rohto Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.15.5 Rohto Recent Development
11.16 Prestige Consumer Healthcare
11.16.1 Prestige Consumer Healthcare Company Details
11.16.2 Prestige Consumer Healthcare Business Overview
11.16.3 Prestige Consumer Healthcare Dry Eye Syndrome Drugs Introduction
11.16.4 Prestige Consumer Healthcare Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.16.5 Prestige Consumer Healthcare Recent Development
11.17 LION
11.17.1 LION Company Details
11.17.2 LION Business Overview
11.17.3 LION Dry Eye Syndrome Drugs Introduction
11.17.4 LION Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.17.5 LION Recent Development
11.18 Kenvue (VISINE)
11.18.1 Kenvue (VISINE) Company Details
11.18.2 Kenvue (VISINE) Business Overview
11.18.3 Kenvue (VISINE) Dry Eye Syndrome Drugs Introduction
11.18.4 Kenvue (VISINE) Revenue in Dry Eye Syndrome Drugs Business (2020-2025)
11.18.5 Kenvue (VISINE) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Novartis
AbbVie
Alcon
Santen Pharma
Johnson & Johnson
Bausch & Lomb
Thea Pharmaceuticals
Ursapharm
SIMILASAN
Akorn
United Laboratories
Sun Pharmaceutical
Jianfeng Group
OmniVision Pharma
ROHTO
Prestige Consumer Healthcare
Lion
Kenvue (VISINE)
List of Tables
 Table 1. Global Dry Eye Syndrome Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Artificial Tears
 Table 3. Key Players of Anti-inflammatory Drugs
 Table 4. Key Players of Other
 Table 5. Global Dry Eye Syndrome Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Dry Eye Syndrome Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Dry Eye Syndrome Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Dry Eye Syndrome Drugs Market Share by Region (2020-2025)
 Table 9. Global Dry Eye Syndrome Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Dry Eye Syndrome Drugs Market Share by Region (2026-2031)
 Table 11. Dry Eye Syndrome Drugs Market Trends
 Table 12. Dry Eye Syndrome Drugs Market Drivers
 Table 13. Dry Eye Syndrome Drugs Market Challenges
 Table 14. Dry Eye Syndrome Drugs Market Restraints
 Table 15. Global Dry Eye Syndrome Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Dry Eye Syndrome Drugs Market Share by Players (2020-2025)
 Table 17. Global Top Dry Eye Syndrome Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Eye Syndrome Drugs as of 2024)
 Table 18. Ranking of Global Top Dry Eye Syndrome Drugs Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Dry Eye Syndrome Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Dry Eye Syndrome Drugs, Headquarters and Area Served
 Table 21. Global Key Players of Dry Eye Syndrome Drugs, Product and Application
 Table 22. Global Key Players of Dry Eye Syndrome Drugs, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Dry Eye Syndrome Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Dry Eye Syndrome Drugs Revenue Market Share by Type (2020-2025)
 Table 26. Global Dry Eye Syndrome Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Dry Eye Syndrome Drugs Revenue Market Share by Type (2026-2031)
 Table 28. Global Dry Eye Syndrome Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Dry Eye Syndrome Drugs Revenue Market Share by Application (2020-2025)
 Table 30. Global Dry Eye Syndrome Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Dry Eye Syndrome Drugs Revenue Market Share by Application (2026-2031)
 Table 32. North America Dry Eye Syndrome Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Dry Eye Syndrome Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Dry Eye Syndrome Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Dry Eye Syndrome Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Dry Eye Syndrome Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Dry Eye Syndrome Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Dry Eye Syndrome Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Dry Eye Syndrome Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Dry Eye Syndrome Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Dry Eye Syndrome Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Dry Eye Syndrome Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Dry Eye Syndrome Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Dry Eye Syndrome Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Dry Eye Syndrome Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Dry Eye Syndrome Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 47. AbbVie Company Details
 Table 48. AbbVie Business Overview
 Table 49. AbbVie Dry Eye Syndrome Drugs Product
 Table 50. AbbVie Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 51. AbbVie Recent Development
 Table 52. Alcon Company Details
 Table 53. Alcon Business Overview
 Table 54. Alcon Dry Eye Syndrome Drugs Product
 Table 55. Alcon Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 56. Alcon Recent Development
 Table 57. Novartis Company Details
 Table 58. Novartis Business Overview
 Table 59. Novartis Dry Eye Syndrome Drugs Product
 Table 60. Novartis Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 61. Novartis Recent Development
 Table 62. Santen Pharma Company Details
 Table 63. Santen Pharma Business Overview
 Table 64. Santen Pharma Dry Eye Syndrome Drugs Product
 Table 65. Santen Pharma Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 66. Santen Pharma Recent Development
 Table 67. Johnson & Johnson Company Details
 Table 68. Johnson & Johnson Business Overview
 Table 69. Johnson & Johnson Dry Eye Syndrome Drugs Product
 Table 70. Johnson & Johnson Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 71. Johnson & Johnson Recent Development
 Table 72. Bausch & Lomb Company Details
 Table 73. Bausch & Lomb Business Overview
 Table 74. Bausch & Lomb Dry Eye Syndrome Drugs Product
 Table 75. Bausch & Lomb Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 76. Bausch & Lomb Recent Development
 Table 77. Thea pharmaceuticals Company Details
 Table 78. Thea pharmaceuticals Business Overview
 Table 79. Thea pharmaceuticals Dry Eye Syndrome Drugs Product
 Table 80. Thea pharmaceuticals Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 81. Thea pharmaceuticals Recent Development
 Table 82. URSAPHARM Company Details
 Table 83. URSAPHARM Business Overview
 Table 84. URSAPHARM Dry Eye Syndrome Drugs Product
 Table 85. URSAPHARM Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 86. URSAPHARM Recent Development
 Table 87. SIMILASAN Company Details
 Table 88. SIMILASAN Business Overview
 Table 89. SIMILASAN Dry Eye Syndrome Drugs Product
 Table 90. SIMILASAN Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 91. SIMILASAN Recent Development
 Table 92. Akorn Company Details
 Table 93. Akorn Business Overview
 Table 94. Akorn Dry Eye Syndrome Drugs Product
 Table 95. Akorn Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 96. Akorn Recent Development
 Table 97. United Laboratories Company Details
 Table 98. United Laboratories Business Overview
 Table 99. United Laboratories Dry Eye Syndrome Drugs Product
 Table 100. United Laboratories Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 101. United Laboratories Recent Development
 Table 102. Sun Pharmaceutical Company Details
 Table 103. Sun Pharmaceutical Business Overview
 Table 104. Sun Pharmaceutical Dry Eye Syndrome Drugs Product
 Table 105. Sun Pharmaceutical Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 106. Sun Pharmaceutical Recent Development
 Table 107. Jianfeng Group Company Details
 Table 108. Jianfeng Group Business Overview
 Table 109. Jianfeng Group Dry Eye Syndrome Drugs Product
 Table 110. Jianfeng Group Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 111. Jianfeng Group Recent Development
 Table 112. OmniVision Pharma Company Details
 Table 113. OmniVision Pharma Business Overview
 Table 114. OmniVision Pharma Dry Eye Syndrome Drugs Product
 Table 115. OmniVision Pharma Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 116. OmniVision Pharma Recent Development
 Table 117. Rohto Company Details
 Table 118. Rohto Business Overview
 Table 119. Rohto Dry Eye Syndrome Drugs Product
 Table 120. Rohto Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 121. Rohto Recent Development
 Table 122. Prestige Consumer Healthcare Company Details
 Table 123. Prestige Consumer Healthcare Business Overview
 Table 124. Prestige Consumer Healthcare Dry Eye Syndrome Drugs Product
 Table 125. Prestige Consumer Healthcare Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 126. Prestige Consumer Healthcare Recent Development
 Table 127. LION Company Details
 Table 128. LION Business Overview
 Table 129. LION Dry Eye Syndrome Drugs Product
 Table 130. LION Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 131. LION Recent Development
 Table 132. Kenvue (VISINE) Company Details
 Table 133. Kenvue (VISINE) Business Overview
 Table 134. Kenvue (VISINE) Dry Eye Syndrome Drugs Product
 Table 135. Kenvue (VISINE) Revenue in Dry Eye Syndrome Drugs Business (2020-2025) & (US$ Million)
 Table 136. Kenvue (VISINE) Recent Development
 Table 137. Research Programs/Design for This Report
 Table 138. Key Data Information from Secondary Sources
 Table 139. Key Data Information from Primary Sources
 Table 140. Authors List of This Report


List of Figures
 Figure 1. Dry Eye Syndrome Drugs Picture
 Figure 2. Global Dry Eye Syndrome Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Dry Eye Syndrome Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Artificial Tears Features
 Figure 5. Anti-inflammatory Drugs Features
 Figure 6. Other Features
 Figure 7. Global Dry Eye Syndrome Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Dry Eye Syndrome Drugs Market Share by Application: 2024 VS 2031
 Figure 9. Hospitals Case Studies
 Figure 10. Clinics Case Studies
 Figure 11. Homecare Case Studies
 Figure 12. Others Case Studies
 Figure 13. Dry Eye Syndrome Drugs Report Years Considered
 Figure 14. Global Dry Eye Syndrome Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Dry Eye Syndrome Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Dry Eye Syndrome Drugs Market Share by Region: 2024 VS 2031
 Figure 17. Global Dry Eye Syndrome Drugs Market Share by Players in 2024
 Figure 18. Global Dry Eye Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 19. The Top 10 and 5 Players Market Share by Dry Eye Syndrome Drugs Revenue in 2024
 Figure 20. North America Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Dry Eye Syndrome Drugs Market Share by Country (2020-2031)
 Figure 22. United States Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Dry Eye Syndrome Drugs Market Share by Country (2020-2031)
 Figure 26. Germany Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Dry Eye Syndrome Drugs Market Share by Region (2020-2031)
 Figure 34. China Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Dry Eye Syndrome Drugs Market Share by Country (2020-2031)
 Figure 42. Mexico Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Dry Eye Syndrome Drugs Market Share by Country (2020-2031)
 Figure 46. Turkey Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Dry Eye Syndrome Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. AbbVie Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
 Figure 50. Alcon Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
 Figure 51. Novartis Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
 Figure 52. Santen Pharma Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
 Figure 53. Johnson & Johnson Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
 Figure 54. Bausch & Lomb Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
 Figure 55. Thea pharmaceuticals Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
 Figure 56. URSAPHARM Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
 Figure 57. SIMILASAN Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
 Figure 58. Akorn Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
 Figure 59. United Laboratories Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
 Figure 60. Sun Pharmaceutical Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
 Figure 61. Jianfeng Group Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
 Figure 62. OmniVision Pharma Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
 Figure 63. Rohto Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
 Figure 64. Prestige Consumer Healthcare Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
 Figure 65. LION Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
 Figure 66. Kenvue (VISINE) Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2020-2025)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Dry Eye Syndrome Market
Global Dry Eye Drugs Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Dry Eye Medication Market
Global Medications for Dry Eye Syndrome Market Research Report 2025
Dry Eye Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dry Eye Treatment Systems Market Research Report 2024
Global Dry Eye Syndrome Eye Drops Market Research Report 2024
Lubricating Eye Drops for Dry Eyes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dry Eye Medications Market Research Report 2024
Global Artificial Tear For Dry Eye Treatment Market Research Report 2024
Global Eye Drops Artificial Tear Market Research Report 2025
Global Eye Drops and Lubricants Drugs Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Artificial Tears and Lubricants Market Research Report 2025
Global Dry or Tired Eye Drops Market Research Report 2024
Global Dry Eye Diagnostic Tools Market Research Report 2024
Global Dry Eye Diagnostic Devices Market Research Report 2024
Global Artificial Tears Market Research Report 2025
OTC Artificial Tears Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dry Eye Comprehensive Tester Market Research Report 2024
Dry Eye Detector Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions